home
PAH
preclinical development
current page
contact

Board of Directors

Anatoly Langer, MD, MSc, FRCPC, FACC

Michael Moniz

Martine Rothblatt, Ph.D., J.D., M.B.A. (Chairman of the Board)

Howard Leong-Poi, MD, FRCPC, FACC, FASE.

Advisor

Duncan Stewart, MD

Management

Eric DesRosiers, Ph.D., M.B.A. - President

Vatche Tchakmakian, CPA - Vice-President Finance

Michael Callahan, MD, DTM&H (UK), MSPH - Chief Medical Officer

John Hess, J.D. - Secretary

David Courtman, Ph.D. - Chief Scientific Officer

Shirley H.J. Mei, M.Sc., Ph.D. - Chief Operating Officer

Josée Champagne, Associate Director Clinical Development

Jackie Whyte, M.Sc., CCRP, - Clinical Trial Manager